Despite intensive research on schizophrenia and its etiology, its pathomechanisms, its early recognition and its optimal treatment, this severe disorder still confronts us with many open questions. The heterogeneous clinical picture of schizophrenia, the overlapping symptomatology with schizoaffective and bipolar disorders as well as the staging of the course of schizophrenia results in an extensive discussion on a revision of current diagnostic classification systems. Despite first path-breaking insights of recent pharmacogenetic studies we are still far away from individualized treatment regimens. Research findings are not easily translated into clinical practice, and the adherence to evidence based guidelines should be improved. Stigma is inhibiting early treatment, it has a negative impact on treatment adherence, and leads to social exclusion and discrimination.
These are just a few examples of the challenges we still have to meet and which may not only require more intensive research and scientific exchange but may also require a redirection of our research strategies. Networking across borders and establishing a forum that allows for periodically updating the knowledge about schizophrenia and for discussing emerging research and clinically relevant issues may help to deal with the aforementioned problems more effectively in future. By bringing together European schizophrenia experts and addressing researchers as well as clinicians the European Conference on Schizophrenia Research (ECSR) shall provide an important contribution to these needs.
The high quality of the scientific program of the ECSR 2009 and the broad range of topics presented is documented in this abstract supplement. Internationally distinguished experts as well as young scientists are contributing to this conference by plenary lectures, presentations within prearranged or submitted symposia, workshops, and poster sessions. Especially the co-organizing psychiatric associations and their schizophrenia sections have a valuable share in this year's ECSR. The fact that the amount of submitted abstracts has more than doubled compared to the initial conference in 2007 in Düsseldorf reflects not only the extensive research in this field but also the successful launch of this bi-annual European schizophrenia conference.
On behalf of the scientific committee and of the organizing psychiatric associations I cordially invite you to participate in this conference. I am looking forward to welcoming you in Berlin. 
